Robert Henkel Net Worth

The estimated Net Worth of Robert J Henkel is at least $530 Thousand dollars as of 17 October 2022. Mr. Henkel owns over 1,000 units of Owens & Minor stock worth over $407,960 and over the last 5 years he sold OMI stock worth over $0. In addition, he makes $122,396 as Independent Director at Owens & Minor.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

or

Sign up with Google Sign up with Facebook

Mr. Henkel OMI stock SEC Form 4 insiders trading

Robert has made over 9 trades of the Owens & Minor stock since 2020, according to the Form 4 filled with the SEC. Most recently he bought 1,000 units of OMI stock worth $15,680 on 17 October 2022.

The largest trade he's ever made was buying 10,000 units of Owens & Minor stock on 7 August 2020 worth over $129,600. On average, Robert trades about 824 units every 26 days since 2019. As of 17 October 2022 he still owns at least 28,000 units of Owens & Minor stock.

You can see the complete history of Mr. Henkel stock trades at the bottom of the page.

Robert Henkel biography

Robert J. Henkel serves as Independent Director of the Company. Mr. Henkel is President, Healthcare Transformation at the THEO Executive Group, since January 2019. Previously, Mr. Henkel served as President and Chief Executive Officer of Ascension Healthcare from 2012 to July, 2017, and was Chief Operating Officer of Ascension Healthcare from 2004 to 2011. Ascension Health, Inc. is the largest non-profit healthcare system in the United States and the world’s largest Catholic health system. During his 25-year tenure with Ascension Health, Mr. Henkel was Chair of the Ascension Innovation Counsel for Ascension Health, Inc. from July 2017 to 2019, and also served in a number of different roles including President of the Great Lakes and Mid-Atlantic States Operating Group. Prior to Ascension Health, Mr. Henkel held numerous executive leadership positions with other healthcare organizations, including the Daughters of Charity National Health System, St. Louis; Mount Sinai Medical Center, Miami Beach, Fla.; SSM Health Care in St. Louis; and Montefiore Medical Center, Bronx, New York. Mr. Henkel is a Life Fellow with the American College of Healthcare Executives and an adjunct professor of health policy and management with the University of Pittsburgh Graduate School of Public Health.

What is the salary of Robert Henkel?

As the Independent Director of Owens & Minor, the total compensation of Robert Henkel at Owens & Minor is $122,396. There are 12 executives at Owens & Minor getting paid more, with Edward Pesicka having the highest compensation of $5,570,490.

How old is Robert Henkel?

Robert Henkel is 65, he's been the Independent Director of Owens & Minor since 2019. There are 2 older and 21 younger executives at Owens & Minor. The oldest executive at Owens & Minor, Inc. is Eddie Moore, 72, who is the Independent Director.

What's Robert Henkel's mailing address?

Robert's mailing address filed with the SEC is OWENS & MINOR, INC., 9120 LOCKWOOD BLVD, MECHANICSVILLE, VA, 23116.

Insiders trading at Owens & Minor

Over the last 21 years, insiders at Owens & Minor have traded over $85,847,692 worth of Owens & Minor stock and bought 130,089 units worth $2,231,834 . The most active insiders traders include Stuart Essig, Edward A Pesicka, and Craig R Smith. On average, Owens & Minor executives and independent directors trade stock every 22 days with the average trade being worth of $213,276. The most recent stock trade was executed by Jonathan A Leon on 22 August 2024, trading 7,500 units of OMI stock currently worth $118,725.

What does Owens & Minor do?

owens & minor, inc. (nyse: omi) is a leading healthcare logistics company dedicated to connecting the world of medical products to the point of care by providing vital supply chain services to healthcare providers and manufacturers of healthcare products. owens & minor provides logistics services across the spectrum of medical products from disposable medical supplies to devices and implants. with logistics platforms strategically located in the united states and europe, owens & minor serves markets where three quarters of global healthcare spending occurs. owens & minor's customers span the healthcare market from independent hospitals to large integrated healthcare networks, as well as group purchasing organizations, healthcare products manufacturers, and the federal government. a fortune 500 company, owens & minor is headquartered in richmond, virginia, and has annualized revenues exceeding $9 billion. for more information about owens & minor, visit the company website at www.owens-m

Complete history of Mr. Henkel stock trades at Owens & Minor

Owens & Minor executives and stock owners

Owens & Minor executives and other stock owners filed with the SEC include:

• Edward Pesicka,
  President, Chief Executive Officer, Director
• Edward A. Pesicka,
  Pres, CEO & Director
• Christopher Lowery,
  President - Global Products
• Andrew G. Long,
  Exec. VP & CFO
• Nicholas Pace,
  Executive Vice President, General Counsel, Corporate Secretary
• Christopher M. Lowery,
  Pres of Global Products
• Jeffrey T. Jochims,
  Exec. VP, COO & Pres of Medical Distribution
• Robert Sledd,
  Independent Chairman of the Board
• Michael Lowry,
  Senior Vice President, Corporate Controller, Chief Accounting Officer
• Mark McGettrick,
  Independent Director
• Eddie Moore,
  Independent Director
• Mark Beck,
  Independent Director
• Robert Henkel,
  Independent Director
• Michael Riordan,
  Independent Director
• Chuck Graves,
  Director - Finance & Investor Relations
• Gwendolyn Bingham,
  Independent Director
• Mark Zacur,
  Senior Vice President, Chief Commercial Officer
• David Myers,
  Senior Vice President, Chief Procurement Officer
• Jonathan Leon,
  Senior Vice President, Corporate Treasurer
• Shana Neal,
  Chief Human Resource Officer, Executive Vice President
• Jeffrey Jochims,
  Chief Operating Officer, Executive Vice President
• Andrew Long,
  Chief Financial Officer, Executive Vice President
• Mark P. Zacur,
  Exec. VP & Chief Commercial Officer
• Shana Carol Neal,
  Exec. VP & Chief HR Officer
• Nicholas Joseph Pace II,
  Exec. VP, Gen. Counsel & Corp. Sec.
• Alex Jost CPA,
  Director of Investor Relations
• Michael Wayne Lowry,
  Sr. VP, Corp. Controller & Chief Accounting Officer
• Carissa Rollins,
  Director
• Aster Angagaw,
  Director
• Stephen W Klemash,
  Director
• Lemuel E Lewis,
  Director
• Martha H. Marsh,
  Director
• Stuart Raymond Morris Hipkins,
  President
• Richard A Meier,
  EVP, Chief Financial Officer
• Rony Camil Kordahi,
  EVP, North American Operations
• Geoff Taylor Marlatt,
  SVP, Manufacturer Services
• Michael Jay Romans,
  SVP, Human Resources
• Richard W Mears,
  Sr. VP, CIO
• Charles C Colpo,
  Senior Vice President
• Craig R Smith,
  President & COO
• Stuart Essig,
  Director
• Stephen Russell Olive,
  SVP, Chief Information Officer
• Erika T Davis,
  Senior. Vice President
• John W Gerdelman,
  Director
• David S Simmons,
  Director
• James E Rogers,
  Director
• Barbara B Hill,
  Director
• Paul Cody Phipps,
  President & CEO
• Timothy P Connolly,
  EVP, Operations & Supply Chain
• Joseph S Pekala,
  SVP, Chief Information Officer
• Robert K Snead,
  EVP, CFO
• Henry A Berling,
  Executive Vice President
• David R Guzman,
  Senior Vice President
• Vernard W Henley,
  Director
• Timothy J Callahan,
  Senior Vice President
• D Andrew Edwards,
  Vice President, Finance
• Daniel Todd Healy,
  SVP, Provider Services
• William Marshall Simpson,
  Group Vice President,
• Jeffrey Kaczka,
  Senior Vice President
• Brian J Shotto,
  SVP, Specialty Services
• Scott W Perkins,
  Senior Vice President
• James B Jr Farinholt,
  Director
• Ev Iii Clarke,
  Group VP, Sales & Distribution
• Richard F Bozard,
  Vice President
• Olwen B Cape,
  Vice President
• J Alfred Jr Broaddus,
  Director
• James E Ukrop,
  Director
• G Gilmer Iii Minor,
  Chairman & CEO
• John T Crotty,
  Director
• Grace R Denttartog,
  Senior Vice President
• A Marshall Acuff,
  Director
• Peter S Redding,
  Director
• James L Bierman,
  SVP, Chief Finanical Officer
• Sumeren Mark A Van,
  Senior Vice President
• Richard E Fogg,
  Director
• Anne M Whittemore,
  Director
• Kenneth Gardner Smith,
  Director
• Tammy L Gomez,
  EVP, CHRO
• Perry A Bernocchi,
  EVP, CEO,. Patient Direct
• Daniel J Starck,
  EVP, Business Excellence
• Alexander J Bruni,
  EVP, CFO
• Heath H Galloway,
  EVP,General Counsel & CorpSecy
• Rita Johnson Mills,
  Director
• Teresa L. Kline,
  Director
• Jennifer A Stone,
  EVP, CHRO
• Snehashish Sarkar,
  EVP, Chief Information Officer